liver and for cancers that are genetically defined. The Company IPO'd recently (total proceeds of $92.9mn) and is a siRNA formulation developer. • Arrowhead Research Corporation (ARWR US) — is conducting research projects in the area of the development of nanotechnologies and applications with the California Institute of Te